Technical Analysis for NMTR - 9 Meters Biopharma, Inc.

Grade Last Price % Change Price Change
D 1.12 -4.27% -0.05
NMTR closed down 4.27 percent on Thursday, April 15, 2021, on 47 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Down
Historical NMTR trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Wide Bands Range Expansion -4.27%
Oversold Stochastic Weakness -4.27%
Narrow Range Bar Range Contraction 0.90%
Wide Bands Range Expansion 0.90%
Oversold Stochastic Weakness 0.90%
Narrow Range Bar Range Contraction 0.90%
Stochastic Reached Oversold Weakness 0.90%
Wide Bands Range Expansion 0.90%
Older End-of-Day Signals for NMTR ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Fell Below Previous Day's Low about 18 hours ago
60 Minute Opening Range Breakdown about 19 hours ago
Down 5% about 19 hours ago
Down 3% about 20 hours ago
10 DMA Resistance about 20 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

9 Meters Biopharma, Inc. operates as a rare, orphan, and unmet needs-focused GI company. The company is advancing its drug candidates for short bowel syndrome and celiac disease. Its product candidates include NM-002, a proprietary long-acting GLP-1 agonist into Phase 2 trial for short bowel syndrome; and larazotide, a Phase 3 tight junction regulator being evaluated for patient-reported symptom improvement in non-responsive celiac disease. The company's pipeline products also includes NM-004, an oral gut restricted immunomodulator and NM-003, a long-acting GLP-2 analogue, both of which are under orphan indication selection. 9 Meters Biopharma, Inc. owns global rights to its products. The company is based in Raleigh, North Carolina.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Organ Systems Gastroenterology Glucagon Like Peptide 1 Biomolecules Celiac Celiac Disease Short Bowel Syndrome

Is NMTR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.25
52 Week Low 0.43
Average Volume 7,333,150
200-Day Moving Average 0.99
50-Day Moving Average 1.57
20-Day Moving Average 1.32
10-Day Moving Average 1.16
Average True Range 0.14
ADX 28.69
+DI 15.72
-DI 30.59
Chandelier Exit (Long, 3 ATRs ) 1.46
Chandelier Exit (Short, 3 ATRs ) 1.43
Upper Bollinger Band 1.75
Lower Bollinger Band 0.88
Percent B (%b) 0.27
BandWidth 65.87
MACD Line -0.12
MACD Signal Line -0.11
MACD Histogram -0.0096
Fundamentals Value
Market Cap 168.36 Million
Num Shares 150 Million
EPS -0.80
Price-to-Earnings (P/E) Ratio -1.40
Price-to-Sales 0.00
Price-to-Book 40.69
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.27
Resistance 3 (R3) 1.27 1.22 1.25
Resistance 2 (R2) 1.22 1.18 1.22 1.24
Resistance 1 (R1) 1.17 1.16 1.15 1.17 1.23
Pivot Point 1.12 1.12 1.11 1.12 1.12
Support 1 (S1) 1.07 1.08 1.05 1.07 1.01
Support 2 (S2) 1.02 1.06 1.02 1.00
Support 3 (S3) 0.97 1.02 1.00
Support 4 (S4) 0.97